Europe Coagulation Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Disease Indications (Vitamin K Deficiency, Liver Disease, Disseminated Intravascular Coagulation & Pulmonary Embolism, Development of Circulating Anticoagulants, Hemophilia, Von Willebrand\'s Disease, and Others), Type [Clinical Laboratory Analyzers (Controls & Calibrators, Assays & Reagents, Instruments/Systems, Coagulation Factors, and Others) and Point-of-Care Testing Analyzers], Offering [Diagnosis (Prothrombin Time Testing, Fibrinogen Testing, Activated Clotting Time Testing, Activated Partial Thromboplastin Time Testing, D-Dimmer Testing, Platelets Function Testing, and Others) and Treatment (Anti-Fibrinolytic Drugs, Birth Control Pills, Desmopressin & Immunosuppressive Medicines, Vitamin K Supplements, Blood Thinners, Thrombin Inhibitors or Thrombolytics, Replacement Therapy, Catheter-Assisted Thrombus Removal, and Others)], Technology (Optical Technology, Mechanical Technology, Electrochemical Technology, and Others), and End User (Clinical Laboratories, Hospitals, and Others)

No. of Pages: 116    |    Report Code: BMIRE00029855    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Coagulation Market

Table of Content

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Coagulation Market - Key Industry Dynamics

4.1 Key Market Drivers:

4.1.1 Increasing Prevalence of Blood Disorders

4.1.2 Rising Prevalence of Cardiovascular Diseases

4.2 Market Restraints

4.2.1 High Costs Associated with Coagulation Analyzers

4.3 Market Opportunities

4.3.1 Growing Organic and Inorganic Strategies by Key Market Players

4.4 Future Trends

4.4.1 Development of Point-of-Care (POC) Coagulation Analyzers

4.5 Impact Analysis

5. Coagulation Market - Europe Market Analysis

5.1 Europe Coagulation Market Revenue (US$ million), 2022 - 2030

6. Europe Coagulation Market - Revenue and Forecast to 2030 - by Disease Indication

6.1 Overview

6.2 Europe Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)

6.3 Vitamin K Deficiency

6.3.1 Overview

6.3.2 Vitamin K Deficiency: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Liver Disease

6.4.1 Overview

6.4.2 Liver Disease: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

6.5 Disseminated Intravascular Coagulation and Pulmonary Embolism

6.5.1 Overview

6.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

6.6 Development of Circulating Anticoagulant

6.6.1 Overview

6.6.2 Development of Circulating Anticoagulant: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

6.7 Hemophilia

6.7.1 Overview

6.7.2 Hemophilia: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

6.8 Von Willebrand's Disease

6.8.1 Overview

6.8.2 Von Willebrand's Disease: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

6.9 Others

6.9.1 Overview

6.9.2 Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Coagulation Market - Revenue and Forecast to 2030 - by Type

7.1 Overview

7.2 Europe Coagulation Market Revenue Share, by Type 2022 & 2030 (%)

7.3 Clinical Laboratory Analyzers

7.3.1 Overview

7.3.2 Clinical Laboratory Analyzers: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

7.3.2.1 Europe Coagulation Market, by Clinical Laboratory Analyzers

7.4 Point-of-Care Testing Analyzers

7.4.1 Overview

7.4.2 Point-of-Care Testing Analyzers: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Coagulation Market - Revenue and Forecast to 2030 - by Offering

8.1 Overview

8.2 Europe Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)

8.3 Diagnosis

8.3.1 Overview

8.3.2 Diagnosis: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

8.3.2.1 Europe Coagulation Market, by Diagnosis

8.4 Treatment

8.4.1 Overview

8.4.2 Treatment: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

8.4.2.1 Europe Coagulation Market, by Treatment

9. Europe Coagulation Market - Revenue and Forecast to 2030 - by Technology

9.1 Overview

9.2 Europe Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)

9.3 Optical Technology

9.3.1 Overview

9.3.2 Optical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Mechanical Technology

9.4.1 Overview

9.4.2 Mechanical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Electrochemical Technology

9.5.1 Overview

9.5.2 Electrochemical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Coagulation Market - Revenue and Forecast to 2030 - by End User

10.1 Overview

10.2 Europe Coagulation Market Revenue Share, by End User 2022 & 2030 (%)

10.3 Clinical Laboratories

10.3.1 Overview

10.3.2 Clinical Laboratories: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

10.4 Hospitals

10.4.1 Overview

10.4.2 Hospitals: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

10.5 Others

10.5.1 Overview

10.5.2 Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Coagulation Market - Country Analysis

11.1 Europe Coagulation Market, Revenue and Forecast to 2030

11.1.1 Europe Coagulation Market by Country

11.1.1.1 Germany

11.1.1.1.1 Overview

11.1.1.1.2 Germany Coagulation Market Revenue and Forecast to 2030 (US$ million)

11.1.1.1.3 Germany Coagulation Market, by Disease Indication

11.1.1.1.4 Germany Coagulation Market, by Type

11.1.1.1.4.1 Germany Coagulation Market, by Clinical Laboratory Analyzers

11.1.1.1.5 Germany Coagulation Market, by Offering

11.1.1.1.5.1 Germany Coagulation Market, by Diagnosis

11.1.1.1.5.2 Germany Coagulation Market, by Treatment

11.1.1.1.6 Germany Coagulation Market, by Technology

11.1.1.1.7 Germany Coagulation Market, by End User

11.1.1.2 UK

11.1.1.2.1 Overview

11.1.1.2.1.1 UK Coagulation Market Revenue and Forecast to 2030 (US$ million)

11.1.1.2.2 UK Coagulation Market, by Disease Indication

11.1.1.2.3 UK Coagulation Market, by Type

11.1.1.2.3.1 UK Coagulation Market, by Clinical Laboratory Analyzers

11.1.1.2.4 UK Coagulation Market, by Offering

11.1.1.2.4.1 UK Coagulation Market, by Diagnosis

11.1.1.2.4.2 UK Coagulation Market, by Treatment

11.1.1.2.5 UK Coagulation Market, by Technology

11.1.1.2.6 UK Coagulation Market, by End User

11.1.1.3 France

11.1.1.3.1 Overview

11.1.1.3.1.1 France Coagulation Market Revenue and Forecast to 2030 (US$ million)

11.1.1.3.2 France Coagulation Market, by Disease Indication

11.1.1.3.3 France Coagulation Market, by Type

11.1.1.3.3.1 France Coagulation Market, by Clinical Laboratory Analyzers

11.1.1.3.4 France Coagulation Market, by Offering

11.1.1.3.4.1 France Coagulation Market, by Diagnosis

11.1.1.3.4.2 France Coagulation Market, by Treatment

11.1.1.3.5 France Coagulation Market, by Technology

11.1.1.3.6 France Coagulation Market, by End User

11.1.1.4 Italy

11.1.1.4.1 Overview

11.1.1.4.1.1 Italy Coagulation Market Revenue and Forecast to 2030 (US$ million)

11.1.1.4.2 Italy Coagulation Market, by Disease Indication

11.1.1.4.3 Italy Coagulation Market, by Type

11.1.1.4.3.1 Italy Coagulation Market, by Clinical Laboratory Analyzers

11.1.1.4.4 Italy Coagulation Market, by Offering

11.1.1.4.4.1 Italy Coagulation Market, by Diagnosis

11.1.1.4.4.2 Italy Coagulation Market, by Treatment

11.1.1.4.5 Italy Coagulation Market, by Technology

11.1.1.4.6 Italy Coagulation Market, by End User

11.1.1.5 Spain

11.1.1.5.1 Overview

11.1.1.5.2 Spain Coagulation Market Revenue and Forecast to 2030 (US$ million)

11.1.1.5.3 Spain Coagulation Market, by Disease Indication

11.1.1.5.4 Spain Coagulation Market, by Type

11.1.1.5.4.1 Spain Coagulation Market, by Clinical Laboratory Analyzers

11.1.1.5.5 Spain Coagulation Market, by Offering

11.1.1.5.5.1 Spain Coagulation Market, by Diagnosis

11.1.1.5.5.2 Spain Coagulation Market, by Treatment

11.1.1.5.6 Spain Coagulation Market, by Technology

11.1.1.5.7 Spain Coagulation Market, by End User

11.1.1.6 Rest of Europe

11.1.1.6.1 Overview

11.1.1.6.2 Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)

11.1.1.6.3 Rest of Europe Coagulation Market, by Disease Indication

11.1.1.6.4 Rest of Europe Coagulation Market, by Type

11.1.1.6.4.1 Rest of Europe Coagulation Market, by Clinical Laboratory Analyzers

11.1.1.6.5 Rest of Europe Coagulation Market, by Offering

11.1.1.6.5.1 Rest of Europe Coagulation Market, by Diagnosis

11.1.1.6.5.2 Rest of Europe Coagulation Market, by Treatment

11.1.1.6.6 Rest of Europe Coagulation Market, by Technology

11.1.1.6.7 Rest of Europe Coagulation Market, by End User

12. Europe Coagulation Market-Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Coagulation Market

12.3 Inorganic Growth Strategies

12.3.1 Overview

12.4 Organic Growth Strategies

12.4.1 Overview

13. Company Profiles

13.1 Siemens Healthineers AG

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 ImproGen Diagnostik Kimya San. & Tic. Ltd.ti.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Nordic Biomarker AB

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Sysmex Corp

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 F. Hoffmann-La Roche Ltd

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Genrui Biotech Co., Ltd.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Transasia Bio-Medicals Ltd

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Horiba Ltd.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

14. Appendix

14.1 About Us

14.2 Glossary of Terms

 

 

List of Tables

Table 1. Europe Coagulation Market Segmentation

Table 2. Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers

Table 3. Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis

Table 4. Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment

Table 5. Optical Technologies and Their Applications

Table 6. Mechanical Technologies and Their Applications

Table 7. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication

Table 8. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type

Table 9. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers

Table 10. Germany Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering

Table 11. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis

Table 12. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment

Table 13. Germany Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology

Table 14. Germany Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User

Table 15. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication

Table 16. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type

Table 17. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers

Table 18. UK Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering

Table 19. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis

Table 20. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment

Table 21. UK Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology

Table 22. UK Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User

Table 23. France Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication

Table 24. France Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type

Table 25. France Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers

Table 26. France Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering

Table 27. France Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis

Table 28. France Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment

Table 29. France Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology

Table 30. France Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User

Table 31. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication

Table 32. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type

Table 33. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers

Table 34. Italy Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering

Table 35. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis

Table 36. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment

Table 37. Italy Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology

Table 38. Italy Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User

Table 39. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication

Table 40. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type

Table 41. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers

Table 42. Spain Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering

Table 43. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis

Table 44. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment

Table 45. Spain Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology

Table 46. Spain Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User

Table 47. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication

Table 48. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type

Table 49. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers

Table 50. Rest of Europe Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering

Table 51. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis

Table 52. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment

Table 53. Rest of Europe Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology

Table 54. Rest of Europe Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User

Table 55. Recent Inorganic Growth Strategies in the Coagulation Market

Table 56. Recent Organic Growth Strategies in the Coagulation Market

Table 57. Glossary of Terms, Coagulation Market

List of Figures

Figure 1. Europe Coagulation Market Segmentation, By Country

Figure 2. Europe Coagulation Market - Key Industry Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Europe Coagulation Market Revenue (US$ million), 2020 - 2030

Figure 5. Europe Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)

Figure 6. Vitamin K Deficiency: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Liver Disease: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Disseminated Intravascular Coagulation and Pulmonary Embolism: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Development of Circulating Anticoagulant: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Hemophilia: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Von Willebrand's Disease: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Europe Coagulation Market Revenue Share, by Type 2022 & 2030 (%)

Figure 14. Clinical Laboratory Analyzers: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Point-of-Care Testing Analyzers: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Europe Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)

Figure 17. Diagnosis: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Treatment: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Europe Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)

Figure 20. Optical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Mechanical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Electrochemical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Europe Coagulation Market Revenue Share, by End User 2022 & 2030 (%)

Figure 25. Clinical Laboratories: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 26. Hospitals: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 27. Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 28. Europe Coagulation Market, By Geography, 2022 ($million)

Figure 29. Europe Coagulation Market, By Key Countries, 2022 and 2030 (%)

Figure 30. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million)

Figure 31. UK Coagulation Market Revenue and Forecast to 2030 (US$ million)

Figure 32. France Coagulation Market Revenue and Forecast to 2030 (US$ million)

Figure 33. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million)

Figure 34. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million)

Figure 35. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)

Figure 36. Growth Strategies in the Coagulation Market

The List of Companies - Europe Coagulation Market

1. F. Hoffmann-La Roche Ltd

2. Genrui Biotech Co., Ltd

3. Horiba Ltd.

4. ImproGen Diagnostik Kimya San. & Tic. Ltd.?ti

5. Nordic Biomarker AB

6. Siemens Healthineers AG

7. Sysmex Corp

8. Transasia Bio-Medicals Ltd